blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4025272

EP4025272 - INJECTION DEVICE FOR DRUG DELIVERY AND PACKAGING FOR THE INJECTION DEVICE [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  05.09.2024
Database last updated on 18.11.2024
FormerRequest for examination was made
Status updated on  10.06.2022
FormerThe international publication has been made
Status updated on  12.03.2021
Formerunknown
Status updated on  28.09.2020
Most recent event   Tooltip19.09.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
[2022/28]
Inventor(s)01 / MISMAR, Wael
C/o Amgen, Inc.
One Amgen Center Drive
Mail Stop 28-5-A
Thousand Oaks, CA 91320-1799 / US
02 / LIU, Jessica, Hai
C/o Amgen, Inc.
One Amgen Center Drive
Mail Stop 28-5-A
Thousand Oaks, CA 91320-1799 / US
03 / BOURELLE, Dylan
C/o Amgen, Inc.
One Amgen Center Drive
Mail Stop 28-5-A
Thousand Oaks, CA 91320-1799 / US
04 / WU, Chia-Jung
C/o Amgen, Inc.
One Amgen Center Drive
Mail Stop 28-5-A
Thousand Oaks, CA 91320-1799 / US
05 / DEVITT, Shaun
C/o Amgen, Inc.
One Amgen Center Drive
Mail Stop 28-5-A
Thousand Oaks, CA 91320-1799 / US
06 / SCHALHOUB, Kenneth, G.
C/o Amgen, Inc.
One Amgen Center Drive
Mail Stop 28-5-A
Thousand Oaks, CA 91320-1799 / US
07 / DESAI, Tej
C/o Amgen, Inc.
One Amgen Center Drive
Mail Stop 28-5-A
Thousand Oaks, CA 91320-1799 / US
08 / DUE, Mads, Schjoth
C/o Amgen, Inc.
One Amgen Center Drive
Mail Stop 28-5-A
Thousand Oaks, CA 91320-1799 / US
09 / BITONG, Anthony
C/o Amgen, Inc.
One Amgen Center Drive
Mail Stop 28-5-A
Thousand Oaks, CA 91320-1799 / US
10 / KESHISHIAN, Arin
C/o Amgen, Inc.
One Amgen Center Drive
Mail Stop 28-5-A
Thousand Oaks, CA 91320-1799 / US
11 / BALLI-CRUZ, Chelsea
C/o Amgen, Inc.
One Amgen Center Drive
Mail Stop 28-5-A
Thousand Oaks, CA 91320-1799 / US
12 / BURQUEL, Pierre
C/o Amgen, Inc.
One Amgen Center Drive
Mail Stop 28-5-A
Thousand Oaks, CA 91320-1799 / US
13 / OBA, Ryan
C/o Amgen, Inc.
One Amgen Center Drive
Mail Stop 28-5-A
Thousand Oaks, CA 91320-1799 / US
14 / GUIRGUIS, Malak
C/o Amgen, Inc.
One Amgen Center Drive
Mail Stop 28-5-A
Thousand Oaks, CA 91320-1799 / US
 [2022/28]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[2022/28]
Application number, filing date20772495.602.09.2020
[2022/28]
WO2020US48975
Priority number, dateUS201962895456P03.09.2019         Original published format: US 201962895456 P
US202063018141P30.04.2020         Original published format: US 202063018141 P
[2022/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021046070
Date:11.03.2021
Language:EN
[2021/10]
Type: A1 Application with search report 
No.:EP4025272
Date:13.07.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 11.03.2021 takes the place of the publication of the European patent application.
[2022/28]
Search report(s)International search report - published on:EP11.03.2021
ClassificationIPC:A61M5/00, A61M5/31
[2022/28]
CPC:
A61M5/001 (EP,IL,US); A61M5/3137 (EP,IL,US); A61K38/179 (IL,US);
A61K39/395 (IL,US); A61M5/002 (EP,IL,US); A61M5/31505 (IL,US);
A61M2005/3139 (EP,IL,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/28]
TitleGerman:INJEKTIONSVORRICHTUNG ZUR WIRKSTOFFABGABE UND VERPACKUNG FÜR DIE INJEKTIONSVORRICHTUNG[2022/28]
English:INJECTION DEVICE FOR DRUG DELIVERY AND PACKAGING FOR THE INJECTION DEVICE[2022/28]
French:DISPOSITIF D'INJECTION DESTINÉ À L'ADMINISTRATION DE MÉDICAMENT ET EMBALLAGE DESTINÉ AU DISPOSITIF D'INJECTION[2022/28]
Entry into regional phase16.03.2022National basic fee paid 
16.03.2022Designation fee(s) paid 
16.03.2022Examination fee paid 
Examination procedure16.03.2022Examination requested  [2022/28]
16.03.2022Date on which the examining division has become responsible
21.10.2022Amendment by applicant (claims and/or description)
04.09.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
21.09.2022Renewal fee patent year 03
20.09.2023Renewal fee patent year 04
19.09.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US5876379  (BEAUVAIS CHARLES K [US], et al);
 [X]US2002198499  (HU CHIEN-KUNG [TW]);
 [X]US2006161114  (PEROT FREDERIC [FR], et al);
 [X]WO2011122351  (TERUMO CORP [JP], et al);
 [X]WO2013028537  (NOXILIZER INC [US], et al);
 [X]WO2014187779  (BAYER PHARMA AG [DE])
by applicantWO0075319
 US7070959
 US7153507
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.